Therefore, GNPs have been considered promising therapeutic agents due to their potential to modulate the main players of RA pathogenesis, including osteoclast, inflammatory cytokines, ROS, and VEGF mediators. This evidence concerns the gene VEGFA and rheumatoid arthritis.